 HOLON, Israel, Feb. 9, 2022 PRNewswire -- Compugen Ltd. NASDAQ: CGEN, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management will present at the 11th Annual SVB Leerink Global Healthcare Conference virtual, on Wednesday, February 16, 2022 at 12:00 pm ET. 